Literature DB >> 34044877

Credelio® Plus: a novel oral endectocide for dogs.

Donato Traversa1.   

Abstract

Entities:  

Year:  2021        PMID: 34044877     DOI: 10.1186/s13071-021-04774-7

Source DB:  PubMed          Journal:  Parasit Vectors        ISSN: 1756-3305            Impact factor:   3.876


× No keyword cloud information.
  5 in total

1.  Effectiveness of Credelio® Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs.

Authors:  Lisa M Young; Scott Wiseman; Elizabeth Crawley; Dwight D Bowman; Craig R Reinemeyer; Daniel E Snyder
Journal:  Parasit Vectors       Date:  2021-05-17       Impact factor: 3.876

Review 2.  Biology and control of ticks infesting dogs and cats in North America.

Authors:  Michael W Dryden; Patricia A Payne
Journal:  Vet Ther       Date:  2004

3.  Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) against natural intestinal nematode infections in dogs presented as veterinary patients in Europe.

Authors:  Brad Hayes; Scott Wiseman; Daniel E Snyder
Journal:  Parasit Vectors       Date:  2021-05-17       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.